We are live on ! Find out more
GCGM

General Catalyst Group Management Portfolio holdings

AUM $184M
1-Year Est. Return 50.45%
This Fund
S&P 500
This Quarter Est. Return
-14.48%
1 Year Est. Return
+50.45%
3 Year Est. Return
+205.57%
5 Year Est. Return
+78.87%
10 Year Est. Return
AUM
$184M
AUM Growth
-$38.2M
Cap. Flow
+$6.67M
Cap. Flow %
3.63%
Top 10 Hldgs %
99.62%
Holding
12
New
5
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 45.56%
2 Healthcare 38.61%
3 Consumer Discretionary 15.17%
4 Financials 0.45%
5 Communication Services 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOT icon
1
Samsara
IOT
$22.9B
$63.4M 34.53%
2,000,000
AVBP icon
2
ArriVent BioPharma
AVBP
$1.36B
$34.5M 18.79%
1,494,786
MAZE
3
Maze Therapeutics
MAZE
$1.5B
$30.9M 16.85%
1,035,910
CART icon
4
Maplebear
CART
$10.8B
$26.6M 14.5%
710,711
GTLB icon
5
GitLab
GTLB
$5.86B
$19.9M 10.86%
921,405
EIKN
6
Eikon Therapeutics
EIKN
$511M
$3.23M 1.76%
+305,233
New +$4.08M
GUTS icon
7
Fractyl Health
GUTS
$111M
$2.24M 1.22%
4,884,193
LIFE
8
Ethos Technologies Inc
LIFE
$1.21B
$829K 0.45%
+74,179
New +$877K
CPNG icon
9
Coupang
CPNG
$27.4B
$692K 0.38%
+36,677
New +$718K
AMZN icon
10
Amazon
AMZN
$2.45T
$538K 0.29%
+2,582
New +$568K
META icon
11
Meta Platforms (Facebook)
META
$1.49T
$376K 0.21%
+658
New +$422K
FIG
12
Figma
FIG
$13.2B
$314K 0.17%
14,845

Similar funds

General Catalyst Group Management's Q1 2026 Portfolio in Review

As of Q1 2026, General Catalyst Group Management held 12 positions worth $184M, down 17% from $222M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

General Catalyst Group Management deployed $6.67M of net new capital in Q1 2026, opening 5 new positions. Its largest new stake was Eikon Therapeutics: 305,233 shares worth $3.23M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 48% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • General Catalyst Group Management's largest Q1 2026 buy was Eikon Therapeutics: 305,233 shares worth $3.23M.
  • General Catalyst Group Management's ten largest holdings make up 100% of its $184M portfolio in Q1 2026.
  • General Catalyst Group Management opened 5 new positions and closed 0 in Q1 2026.
  • General Catalyst Group Management's portfolio value fell 17% quarter-over-quarter to $184M.

Based on General Catalyst Group Management's 13F filing for Q1 2026, filed 15 May 2026.